BSX vs. COO

Last updated Apr 1, 2026

Compare and contrast key facts about Boston Scientific Corporation (BSX) and The Cooper Companies, Inc. (COO).

Performance

BSX vs. COO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Boston Scientific Corporation (BSX) and The Cooper Companies, Inc. (COO). The values are adjusted to include any dividend payments, if applicable.

BSX vs. COO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BSX Boston Scientific Corporation	-34.19%	6.75%	54.51%	24.94%	8.92%	18.16%	-20.50%	27.96%	42.56%	14.61%
COO The Cooper Companies, Inc.	-12.76%	-10.85%	-2.83%	14.47%	-21.06%	15.33%	13.10%	26.27%	16.84%	24.59%

Fundamentals

Market Cap BSX : $93.86B COO : $14.06B
EPS BSX : $1.93 COO : $2.02
PE Ratio BSX : 32.46 COO : 35.45
PS Ratio BSX : 4.67 COO : 3.43
PB Ratio BSX : 3.87 COO : 1.68
Total Revenue (TTM) BSX : $20.08B COO : $4.15B
Gross Profit (TTM) BSX : $13.85B COO : $2.67B
EBITDA (TTM) BSX : $4.91B COO : $962.00M

Returns By Period

In the year-to-date period, BSX achieves a -34.19% return, which is significantly lower than COO's -12.76% return. Over the past 10 years, BSX has outperformed COO with an annualized return of 12.73%, while COO has yielded a comparatively lower 6.16% annualized return.

BSX

• 1D: -0.29%
• 1M: -18.35%
• YTD: -34.19%
• 6M: -35.73%
• 1Y: -37.80%
• 3Y*: 7.84%
• 5Y*: 10.22%
• 10Y*: 12.73%

COO

• 1D: 3.16%
• 1M: -14.55%
• YTD: -12.76%
• 6M: 4.29%
• 1Y: -15.23%
• 3Y*: -8.50%
• 5Y*: -5.79%
• 10Y*: 6.16%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

BSX vs. COO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BSX

BSX Risk / Return Rank: 4
BSX Sharpe Ratio Rank: 2
BSX Sortino Ratio Rank: 5
BSX Omega Ratio Rank: 3
BSX Calmar Ratio Rank: 9
BSX Martin Ratio Rank: 0

COO

COO Risk / Return Rank: 21
COO Sharpe Ratio Rank: 22
COO Sortino Ratio Rank: 22
COO Omega Ratio Rank: 22
COO Calmar Ratio Rank: 21
COO Martin Ratio Rank: 20

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BSX vs. COO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Boston Scientific Corporation (BSX) and The Cooper Companies, Inc. (COO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BSX	COO	Difference
Sharpe ratio Return per unit of total volatility	-1.21	-0.44	-0.78
Sortino ratio Return per unit of downside risk	-1.59	-0.38	-1.20
Omega ratio Gain probability vs. loss probability	0.75	0.95	-0.19
Calmar ratio Return relative to maximum drawdown	-0.88	-0.61	-0.26
Martin ratio Return relative to average drawdown	-2.47	-1.16	-1.31
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BSX vs. COO - Sharpe Ratio Comparison

The current BSX Sharpe Ratio is -1.21, which is lower than the COO Sharpe Ratio of -0.44. The chart below compares the historical Sharpe Ratios of BSX and COO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	BSX	COO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-1.21	-0.44	-0.78
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.42	-0.20	+0.63
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.48	0.22	+0.25
Sharpe Ratio (All Time) Calculated using the full available price history	0.22	0.12	+0.10

Correlation

The correlation between BSX and COO is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

BSX vs. COO - Dividend Comparison

Neither BSX nor COO has paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BSX Boston Scientific Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
COO The Cooper Companies, Inc.	0.00%	0.00%	0.00%	0.02%	0.02%	0.01%	0.02%	0.02%	0.02%	0.03%	0.03%	0.04%

Drawdowns

BSX vs. COO - Drawdown Comparison

The maximum BSX drawdown since its inception was -89.15%, smaller than the maximum COO drawdown of -98.88%. Use the drawdown chart below to compare losses from any high point for BSX and COO.

Drawdown Indicators

	BSX	COO	Difference
Max Drawdown Largest peak-to-trough decline	-89.15%	-98.88%	+9.73%
Max Drawdown (1Y) Largest decline over 1 year	-41.97%	-23.83%	-18.14%
Max Drawdown (5Y) Largest decline over 5 years	-41.97%	-45.45%	+3.48%
Max Drawdown (10Y) Largest decline over 10 years	-43.49%	-45.45%	+1.96%
Current Drawdown Current decline from peak	-41.97%	-37.25%	-4.72%
Average Drawdown Average peak-to-trough decline	-38.71%	-40.55%	+1.84%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.94%	12.66%	+2.28%

Volatility

BSX vs. COO - Volatility Comparison

Boston Scientific Corporation (BSX) has a higher volatility of 11.48% compared to The Cooper Companies, Inc. (COO) at 8.16%. This indicates that BSX's price experiences larger fluctuations and is considered to be riskier than COO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BSX	COO	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.48%	8.16%	+3.32%
Volatility (6M) Calculated over the trailing 6-month period	27.07%	18.98%	+8.09%
Volatility (1Y) Calculated over the trailing 1-year period	31.31%	35.02%	-3.71%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	24.21%	28.68%	-4.47%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	26.76%	27.61%	-0.85%

Financials

BSX vs. COO - Profitability Comparison

The chart below illustrates the profitability comparison between Boston Scientific Corporation and The Cooper Companies, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

BSX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Boston Scientific Corporation reported a gross profit of 3.94B and revenue of 5.29B. Therefore, the gross margin over that period was 74.5%.

COO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, The Cooper Companies, Inc. reported a gross profit of 695.20M and revenue of 1.02B. Therefore, the gross margin over that period was 67.9%.

BSX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Boston Scientific Corporation reported an operating income of 1.21B and revenue of 5.29B, resulting in an operating margin of 22.8%.

COO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, The Cooper Companies, Inc. reported an operating income of 212.80M and revenue of 1.02B, resulting in an operating margin of 20.8%.

BSX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Boston Scientific Corporation reported a net income of 668.00M and revenue of 5.29B, resulting in a net margin of 12.6%.

COO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, The Cooper Companies, Inc. reported a net income of 130.80M and revenue of 1.02B, resulting in a net margin of 12.8%.